Allied Corp Teams Up With Blueberries Medical To Produce Psychoactive And Non-Psychoactive Derivatives

Allied Corp. ALID, a cannabis cultivator based in Colombia and one of the few to have executed on international exports, announced that it has signed a joint venture agreement with Blueberries Medical Corp. BBRRF, an extraction company in Colombia, to produce psychoactive and non-psychoactive derivatives.

By combining Allied’s expertise in producing quality flower with Blueberries’ extraction facilities, the companies will join forces in sales effort, while optimizing production capabilities. In addition to offering large volumes of cannabis flower from Colombia, Allied will now be enabled to offer quality derivative-based products within markets it currently distributes and expand its global presence.

Allied’s and Blueberries clients and supply channel partners span five world continents that include Australia, Europe, Asia, South America and North America.

“We are excited to partner with Blueberries to offer derivative products to the global markets that we are currently working in and beyond.” stated Calum Hughes, CEO and chairman of the board.

Photo: Benzinga edit with photos by geralt, lindsayfox on Pixabay

Related News

Allied Corp's First THC Flower Harvests Now Offered For Sale And Export From Colombia

1.000 Pounds Of Dry Cannabis Have Been Exported From Colombia In Less Than One Month

Allied Corp Ships Second Commercial Cannabis Flower Export From Colombia To International Market